PAVmed (PAVM) Financials

$5.20

$-0.09 (-1.61%)

As on 08-Sep-2026 10:10EDT

Market cap

$42 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

1.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	0.11	0.07	3.00	2.45	0.38	0.50
Cost of Revenue	0.40	0.32	6.04	6.42	3.61	0.59
Gross Profit	-0.29	-0.25	-3.04	-3.97	-3.24	-0.09
Operating Expenses	26.42	21.55	41.44	64.83	87.85	54.31
Operating Profit (EBIT)	-26.70	-21.81	-44.49	-68.80	-91.09	-54.39
Other Income	--	--	--	--	--	-1.73
Profit before Tax	-16.43	-2.47	28.43	-79.26	-103.24	-56.13
Provision for Tax	6,241.00	1,305.00	-3,539.00	-12,993.00	-1.94	-5.78
Profit after Tax (Net Income)	-12.09	0.40	39.79	-64.18	-88.98	-50.35
Minority Interest	3.13	2.87	11.36	15.83	14.26	5.78
Consolidated Profit	--	--	--	--	-89.26	-50.63

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	35.05	33.97	-2.50	-53.83	-9.68	61.67
Minority Interest	3.13	--	--	--	--	17.75
Non-Current Liabilities	16.82	1.68	2.25	2.96	1.85	3.30
Current Liabilities	4.09	14.84	35.45	54.18	41.20	7.56
Total Liabilities	44.30	38.81	30.66	33.12	53.98	86.98

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	35.36	36.26	28.50	8.62	10.05	4.34
Current Assets	4.86	2.56	2.16	24.50	43.93	82.64
Total Assets	45.07	38.81	30.66	33.12	53.98	86.98
Total Debt*	17.07	13.35	31.86	48.73	36.64	--
Net Current Assets	--	-12.28	-33.28	-29.68	2.73	75.08

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-5,206.00	-33.55	-52.04	-70.99	-40.59
Cash Flow from Investing Activities	--	-31.00	-16.18	0.76	-4.74	-3.72
Cash from Financing Activities	--	5,590.00	31.28	31.17	38.21	104.31
Net Cash Inflow / Outflow	--	--	--	--	--	60.00

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-10.02	0.52	106.59	-240.00	-423.73	-0.58
Cash EPS ($)	--	0.65	109.80	-229.03	-412.03	-0.58
Adjusted Book Value ($)	--	43.91	--	--	--	0.71
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-6,729.58	-89.88	-194.60	-338.02	-0.47
Free Cash Flow per Share ($)	--	-6,729.58	-90.03	-195.50	-345.36	-0.49

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	1.05	328.05	-587.41	-200.81	-128.24
ROE (%)	-25.98	2.55	-141.29	202.09	-342.34	-158.42
ROA (%)	-24.31	1.15	124.78	-147.36	-126.26	-94.32
EBIT Margin (%)	-8,764.29	-3,447.89	950.65	-3,208.56	-27,044.30	-11,225.20
Net Margin (%)	-10,794.64	564.79	1,328.58	-2,617.25	-23,602.92	4,083.29
Cash Profit Margin (%)	-0.18	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-89.02	-0.98	0.22	5.50	-0.25	--
EBIT Growth (%)	-114.40	-108.60	136.19	22.84	-81.66	-140.36
Net Profit Growth (%)	-111.55	-98.99	162.00	27.88	-76.74	-46.89
EPS Growth (%)	-126.14	-1.00	1.44	0.43	-725.89	1.00
Book Value Growth (%)	-91.74	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	0.43	0.01	-0.02	0.00	-4.22
Price / Book Value	1.29	0.01	-0.09	-0.02	-0.01	3.45
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	25.79	-5.11	1.03	-0.36	0.06	-2.38
Close Price ($)	5.94	6.62	18.83	123.60	216.00	1,107.00
High Price ($)	28.44	26.85	128.70	295.92	1,178.96	4,365.00
Low Price ($)	3.88	6.30	17.16	82.50	180.45	882.00
Market Cap ($ Cr)	42.22	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.39	-12.77	-0.91	-3.78	--
Short term debt to equity ratio	0.02	0.34	-11.87	-0.85	-3.59	--
Current Ratio	1.19	0.17	0.06	0.45	1.07	10.93
Quick Ratio	1.19	0.16	0.05	0.44	1.06	10.86
Interest Coverage	-911.78	-116.57	632.71	-133.57	-79.59	-9.71

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	14.29	21.13	0.60	2.49	4.51	40.00
Asset Turnover	0.00	0.00	0.09	0.06	0.01	0.01
Receivable days	--	84.88	4.82	5.81	105.12	73.05
Inventory Days	--	285.53	24.35	22.76	39.77	431.12
Payable days	--	754.81	73.89	127.72	303.35	1,955.80
Cash Conversion Cycle	--	-384.40	-44.73	-99.16	-158.46	-1,451.63

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.